麻豆传媒

It took 2 years of insurance rigamarole, but 3 months post-op, she's lost 66 pounds

However, many expect demand to come back eventually

Tirzepatide ok'd for obstructive sleep apnea in people with obesity

Compounders only have 2 to 3 months left to copy injectable

News and commentary from the endocrinology world

Why it's unlikely to help most people

Health news and commentary gathered by 麻豆传媒 staff

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

20% lower risk of VTE observed in large retrospective study of diabetes patients

Physicians, policymakers raise questions about LillyDirect connecting patients with telehealth

Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide

Experts tackle access, equity, and the blockbuster drugs reshaping healthcare

News and commentary from the endocrinology world